Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0012739 (
disseminated intravascular coagulation
)
8,673
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The neurotoxicity of
L-DOPA
and dopamine (DA) on striatal neurons was examined by using primary cultures of rat striatum. Exposure to
L-DOPA
and DA at concentrations of 30-300 microM induced dose-dependent cell death in both younger cultures (3 days in culture, 3
DIC
) and elder cultures (10 days in culture, 10
DIC
). The cytotoxicity of
L-DOPA
and DA was also dependent on the exposure time (6-24 h). Ascorbic acid (200 microM) inhibited both
L-DOPA
- and DA-induced cytotoxicity in 3
DIC
cultures, whereas it provided significant protection against DA- but not
L-DOPA
-induced cytotoxicity in 10
DIC
cultures. The
L-DOPA
cytotoxicity in 10
DIC
cultures was prevented by a non-NMDA receptor antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and by an NMDA receptor antagonist, MK-801. Neither antagonist prevented DA cytotoxicity. D-
DOPA
did not affect the viability of 10
DIC
cultures, though it elicited marked toxicity in 3
DIC
cultures. These results suggest that there are two components in the mechanisms that mediate the
L-DOPA
neurotoxicity on striatal neurons: one is autoxidation-relevant and the other is autoxidation-irrelevant. With respect to the latter, glutamate receptor stimulation may be involved. In contrast, autoxidation plays an important role in DA neurotoxicity.
...
PMID:Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. 901 56